Retina Consultants San Diego

Retina Consultants San Diego (RCSD) is a premier clinical practice and research center specializing in the diagnosis and treatment of vitreoretinal diseases. Founded in 1979, the organization provides advanced medical and surgical care for conditions such as macular degeneration, diabetic retinopathy, and retinal detachment. RCSD is a prominent clinical trial site, partnering with major biopharmaceutical companies to conduct Phase 1 through Phase 3 studies for next-generation ophthalmic therapies, including gene therapies and novel biologics. The practice is a member of the Retina Consultants of America (RCA) network, which was acquired by Cencora in 2025. With multiple locations across the San Diego region, RCSD integrates high-level patient care with a robust clinical research infrastructure.